{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:27:42Z","timestamp":1781612862531,"version":"3.54.5"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurochir"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00701-015-2376-x","type":"journal-article","created":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T10:24:55Z","timestamp":1427970295000},"page":"985-991","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of magnesium on functional outcome and paraclinical parameters of patients undergoing supratentorial craniotomy for brain tumors: a randomized controlled trial"],"prefix":"10.1007","volume":"157","author":[{"given":"Bahador","family":"Mirrahimi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abolghasem","family":"Mortazavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Ketabchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abass","family":"Amirjamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asieh","family":"Ashouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Khajavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2160-9301","authenticated-orcid":false,"given":"Mojtaba","family":"Mojtahedzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,1]]},"reference":[{"key":"2376_CR1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0973-0508(08)80025-1","volume":"5","author":"S Dhandapani","year":"2008","unstructured":"Dhandapani S, Gupta A, Vivekanandhan S, Sharma B, Mahapatra A (2008) Randomized controlled trial of magnesium sulphate in severe closed traumatic brain injury. Indian J Neurotrauma 5:27\u201333","journal-title":"Indian J Neurotrauma"},{"key":"2376_CR2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.brainres.2010.11.057","volume":"1371","author":"SW Kang","year":"2011","unstructured":"Kang SW, Choi SK, Park E, Chae SJ, Choi S, Jin Joo H, Lee GJ, Park HK (2011) Neuroprotective effects of magnesium-sulfate on ischemic injury mediated by modulating the release of glutamate and reduced of hyperreperfusion. Brain Res 1371:121\u20138","journal-title":"Brain Res"},{"key":"2376_CR3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9343(94)90117-1","volume":"96","author":"RM McLean","year":"1994","unstructured":"McLean RM (1994) Magnesium and its therapeutic uses: a review. Am J Med 96:63\u201376","journal-title":"Am J Med"},{"key":"2376_CR4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1056\/NEJMoa021180","volume":"348","author":"MA Belfort","year":"2003","unstructured":"Belfort MA, Anthony J, Saade GR, Allen JC Jr, Nimodipine Study G (2003) A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 348:304\u201311","journal-title":"N Engl J Med"},{"key":"2376_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1474-4422(06)70630-5","volume":"6","author":"NR Temkin","year":"2007","unstructured":"Temkin NR, Anderson GD, Winn HR, Ellenbogen RG, Britz GW, Schuster J, Lucas T, Newell DW, Mansfield PN, Machamer JE, Barber J, Dikmen SS (2007) Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol 6:29\u201338","journal-title":"Lancet Neurol"},{"key":"2376_CR6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/neu.2000.17.53","volume":"17","author":"I Cernak","year":"2000","unstructured":"Cernak I, Savic VJ, Kotur J, Prokic V, Veljovic M, Grbovic D (2000) Characterization of plasma magnesium concentration and oxidative stress following graded traumatic brain injury in humans. J Neurotrauma 17:53\u201368","journal-title":"J Neurotrauma"},{"key":"2376_CR7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/neu.1988.5.17","volume":"5","author":"TK McIntosh","year":"1988","unstructured":"McIntosh TK, Faden AI, Yamakami I, Vink R (1988) Magnesium deficiency exacerbates and pretreatment improves outcome following traumatic brain injury in rats: 31P magnetic resonance spectroscopy and behavioral studies. J Neurotrauma 5:17\u201331","journal-title":"J Neurotrauma"},{"key":"2376_CR8","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1089\/neu.2000.17.1029","volume":"17","author":"FM Bareyre","year":"2000","unstructured":"Bareyre FM, Saatman KE, Raghupathi R, McIntosh TK (2000) Postinjury treatment with magnesium chloride attenuates cortical damage after traumatic brain injury in rats. J Neurotrauma 17:1029\u201339","journal-title":"J Neurotrauma"},{"key":"2376_CR9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/jnen\/60.2.183","volume":"60","author":"KE Saatman","year":"2001","unstructured":"Saatman KE, Bareyre FM, Grady MS, McIntosh TK (2001) Acute cytoskeletal alterations and cell death induced by experimental brain injury are attenuated by magnesium treatment and exacerbated by magnesium deficiency. J Neuropathol Exp Neurol 60:183\u201394","journal-title":"J Neuropathol Exp Neurol"},{"key":"2376_CR10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0361-9230(03)00089-3","volume":"61","author":"KJ Lamers","year":"2003","unstructured":"Lamers KJ, Vos P, Verbeek MM, Rosmalen F, van Geel WJ, van Engelen BG (2003) Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients. Brain Res Bull 61:261\u20134","journal-title":"Brain Res Bull"},{"key":"2376_CR11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10143-011-0368-8","volume":"35","author":"T Hassan","year":"2012","unstructured":"Hassan T, Nassar M, Elhadi SM, Radi WK (2012) Effect of magnesium sulfate therapy on patients with aneurysmal subarachnoid hemorrhage using serum S100B protein as a prognostic marker. Neurosurg Rev 35:421\u20137, discussion 427","journal-title":"Neurosurg Rev"},{"key":"2376_CR12","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.clinbiochem.2012.07.094","volume":"45","author":"S Gonzalez-Garcia","year":"2012","unstructured":"Gonzalez-Garcia S, Gonzalez-Quevedo A, Fernandez-Concepcion O, Pena-Sanchez M, Menendez-Sainz C, Hernandez-Diaz Z, Arteche-Prior M, Pando-Cabrera A, Fernandez-Novales C (2012) Short-term prognostic value of serum neuron specific enolase and S100B in acute stroke patients. Clin Biochem 45:1302\u20137","journal-title":"Clin Biochem"},{"key":"2376_CR13","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.3109\/02699052.2012.694567","volume":"26","author":"P Gradisek","year":"2012","unstructured":"Gradisek P, Osredkar J, Korsic M, Kremzar B (2012) Multiple indicators model of long-term mortality in traumatic brain injury. Brain Inj 26:1472\u201381","journal-title":"Brain Inj"},{"key":"2376_CR14","first-page":"477","volume":"17","author":"N Hendoui","year":"2013","unstructured":"Hendoui N, Beigmohammadi MT, Mahmoodpoor A, Ahmadi A, Abdollahi M, Hasanpour M, Hadi F, Khazaeipour Z, Mousavi S, Mojtahedzadeh M (2013) Reliability of calcium-binding protein S100B measurement toward optimization of hyperosmolal therapy in traumatic brain injury. Eur Rev Med Pharmacol Sci 17:477\u201385","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2376_CR15","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/pr401111h","volume":"13","author":"E Martinez-Morillo","year":"2014","unstructured":"Martinez-Morillo E, Garcia Hernandez P, Begcevic I, Kosanam H, Prieto Garcia B, Alvarez Menendez FV, Diamandis EP (2014) Identification of novel biomarkers of brain damage in patients with hemorrhagic stroke by integrating bioinformatics and mass spectrometry-based proteomics. J Proteome Res 13:969\u201381","journal-title":"J Proteome Res"},{"key":"2376_CR16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/STROKEAHA.109.571125","volume":"41","author":"GK Wong","year":"2010","unstructured":"Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, Zee BC, Investigators I (2010) Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke 41:921\u20136","journal-title":"Stroke"},{"key":"2376_CR17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.fertnstert.2009.02.024","volume":"94","author":"A Apostol","year":"2010","unstructured":"Apostol A, Apostol R, Ali E, Choi A, Ehsuni N, Hu B, Li L, Altura BT, Altura BM (2010) Cerebral spinal fluid and serum ionized magnesium and calcium levels in preeclamptic women during administration of magnesium sulfate. Fertil Steril 94:276\u201382","journal-title":"Fertil Steril"},{"key":"2376_CR18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00008506-199710000-00006","volume":"9","author":"T Fuchs-Buder","year":"1997","unstructured":"Fuchs-Buder T, Tramer MR, Tassonyi E (1997) Cerebrospinal fluid passage of intravenous magnesium sulfate in neurosurgical patients. J Neurosurg Anesthesiol 9:324\u20138","journal-title":"J Neurosurg Anesthesiol"},{"key":"2376_CR19","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.TA.0000037876.37236.D6","volume":"54","author":"E Jeremitsky","year":"2003","unstructured":"Jeremitsky E, Omert L, Dunham CM, Protetch J, Rodriguez A (2003) Harbingers of poor outcome the day after severe brain injury: hypothermia, hypoxia, and hypoperfusion. J Trauma 54:312\u20139","journal-title":"J Trauma"},{"key":"2376_CR20","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1001\/archsurg.136.10.1118","volume":"136","author":"G Manley","year":"2001","unstructured":"Manley G, Knudson MM, Morabito D, Damron S, Erickson V, Pitts L (2001) Hypotension, hypoxia, and head injury: frequency, duration, and consequences. Arch Surg 136:1118\u201323","journal-title":"Arch Surg"},{"key":"2376_CR21","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1186\/cc6887","volume":"12","author":"G Xiao","year":"2008","unstructured":"Xiao G, Wei J, Yan W, Wang W, Lu Z (2008) Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 12:R61","journal-title":"Crit Care"},{"key":"2376_CR22","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/01.ta.0000196002.03681.18","volume":"59","author":"DH Livingston","year":"2005","unstructured":"Livingston DH, Lavery RF, Mosenthal AC, Knudson MM, Lee S, Morabito D, Manley GT, Nathens A, Jurkovich G, Hoyt DB, Coimbra R (2005) Recovery at 1\u00a0year following isolated traumatic brain injury: a Western Trauma Association prospective multicenter trial. J Trauma 59:1298\u2013304, discussion 1304","journal-title":"J Trauma"},{"key":"2376_CR23","first-page":"134","volume":"57","author":"SS Mehta","year":"2010","unstructured":"Mehta SS (2010) Biochemical serum markers in head injury: an emphasis on clinical utility. Clin Neurosurg 57:134\u201340","journal-title":"Clin Neurosurg"},{"key":"2376_CR24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/13547500903015784","volume":"14","author":"ML James","year":"2009","unstructured":"James ML, Blessing R, Phillips-Bute BG, Bennett E, Laskowitz DT (2009) S100B and brain natriuretic peptide predict functional neurological outcome after intracerebralhaemorrhage. Biomarkers 14:388\u201394","journal-title":"Biomarkers"},{"key":"2376_CR25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.clineuro.2005.12.006","volume":"108","author":"MT Wunderlich","year":"2006","unstructured":"Wunderlich MT, Lins H, Skalej M, Wallesch CW, Goertler M (2006) Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke. Clin Neurol Neurosurg 108:558\u201363","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Acta Neurochirurgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-015-2376-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00701-015-2376-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00701-015-2376-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:21:06Z","timestamp":1559089266000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00701-015-2376-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,1]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2376"],"URL":"https:\/\/doi.org\/10.1007\/s00701-015-2376-x","relation":{},"ISSN":["0001-6268","0942-0940"],"issn-type":[{"value":"0001-6268","type":"print"},{"value":"0942-0940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,1]]}}}